Complications of continuous intraperitoneal insulin infusion with an implantable pump

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

440

HTML

2634

Figures (1-1)

211

Tables (1-3)

211

Sum=3496

Aug 15, 2012 (publication date) through Nov 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Diabetes. Aug 15, 2012; 3(8): 142-148
Published online Aug 15, 2012. doi: 10.4239/wjd.v3.i8.142

Table 1 Baseline characteristics of patients starting continuous intraperitoneal insulin infusion n (%)

	All patients	Implantation date
	2000-2011 (n = 56)	2000-2007 (n = 37)	2007-2011 (n = 19)
Age (mean ± SD, yr)	37.6 ± 14.5	38.0 ± 14.4	36.6 ± 15.1
Female sex	38 (68)	28 (76)	10 (53)
Smokers	12 (21.4)	7 (18.9)	5 (26.3)
Previous abdominal operation	9 (16.1)	7 (18.9)	2 (10.5)
BMI (mean ± SD, kg/m²)	25.4 ± 4.4	26.3 ± 4.2	23.7 ± 4.3
Duration of diabetes (yr), median (IQR)	16.7 (9.7-26.3)	15.9 (9.8-26.8)	19.1 (9.6-26.3)
Retinopathy	13 (23.2)	9 (24.3)	4 (21.1)
Neuropathy	17 (30.4)	12 (32.4)	5 (26.3)
Nephropathy	4 (7.1)	3 (8.0)	1 (5.3)

BMI: Body mass index; IQR: Interquartile range.

Citation: Dijk PRV, Logtenberg SJ, Groenier KH, Haveman JW, Kleefstra N, Bilo HJ. Complications of continuous intraperitoneal insulin infusion with an implantable pump. World J Diabetes 2012; 3(8): 142-148
URL: https://www.wjgnet.com/1948-9358/full/v3/i8/142.htm
DOI: https://dx.doi.org/10.4239/wjd.v3.i8.142